Author: Guina Jeffrey Merrill Brian
Publisher: MDPI
E-ISSN: 2077-0383|7|2|17-17
ISSN: 2077-0383
Source: Journal of Clinical Medicine, Vol.7, Iss.2, 2018-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Benzodiazepines are some of the most commonly prescribed medications in the world. These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia, but are also linked to a variety of adverse effects (whether used long-term, short-term, or as needed). Many patients take benzodiazepines long-term without ever receiving evidence-based first-line treatments (e.g., psychotherapy, relaxation techniques, sleep hygiene education, serotonergic agents). This review discusses the risks and benefits of, and alternatives to benzodiazepines. We discuss evidence-based indications and contraindications, and the theoretical biopsychosocial bases for effectiveness, ineffectiveness and harm. Potential adverse effects and drug-drug interactions are summarized. Finally, both fast-acting/acute and delayed-action/chronic alternative treatments for anxiety and/or insomnia are discussed. Response to treatment—whether benzodiazepines, other pharmacological agents, or psychotherapy—should be determined based on functional recovery and not merely sedation.
Related content
Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation
Healthcare, Vol. 3, Iss. 2, 2015-04 ,pp. :
Vitamin D and the Athlete: Risks, Recommendations, and Benefits
Nutrients, Vol. 5, Iss. 6, 2013-05 ,pp. :